FDA Seeks Comment on AI CAD Device Oversight Proposal
ACR to comment on FDA plan for optional premarket flexibility for CAD devices with added post-market monitoring.
Read moreFDA Seeks Comment on AI CAD Device Oversight Proposal
ACR to comment on FDA plan for optional premarket flexibility for CAD devices with added post-market monitoring.
Read moreWhite House Moves to Challenge State AI Laws
White House orders review of state AI laws, pushes for a national framework; agencies may withhold funds over conflicting rules.
Read moreACR Chair Takes Part in IAEA Radiation Protection Conference
ACR Chair Alan Matsumoto, MD, joined global leaders at IAEA conference on radiation protection in medicine.
Read more